-----Original Message-----
From: U.S. Food & Drug Administration (FDA)
Sent: 11/9/2011 9:22:29 PM
To: guyperea@live.com
Subject: Drug Information Update - CDER Small Business Update: Introduction to the Drug Master File Webinar, November 14, 2011
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
Introduction to the Drug Master File (DMF) Webinar - November 14, 2011
On Monday, November 14, 2011 at 11:00 a.m. (ET), our CDER Small Business Assistance Program will present our webinar entitled Introduction to the Drug Master File (DMF) which will discuss all aspects of filing a DMF, including when and why to submit a DMF; requirements and recommendations for formatting and submitting original DMFs and subsequent submissions; how DMFs are reviewed and common problems.
Our presenter will be Dr. Arthur Shaw who is CDER’s DMF Expert, in addition to being a Quality Reviewer in the Office of New Drug Quality Assessment (ONDQA). He has extensive experience in dealing with DMF filing and database issues, as well as reviewing many DMFs for technical content as part of his daily review work to support New Drug Applications (NDAs) and Investigational New Drug (IND) applications.
Dr. Shaw’s previous positions in FDA include Special Assistant in the Office of New Drug Chemistry and Review Chemist in the Division of Gastrointestinal and Coagulation Drug Products and in the Division of Pulmonary and Allergy Drug Products. Dr. Shaw received a B.S. in chemistry (with Honors) from the City College of New York and a Ph.D. in biochemistry at Cornell University.
Registration website: https://collaboration.fda.gov/dmf/event/registration.html
Web Address for viewing on day of event: https://collaboration.fda.gov/dmf/event/login.html
Call in numbers (listen only mode):
Domestic: 1-800-857-0171
International: 1-517-319-9290
Password (verbal): 2718839
For More Information:
http://www.fda.gov/smallbusinessdrugs
Click on Workshops and Webinars in Spotlight box
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to guyperea@live.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
No comments:
Post a Comment